ID
IDenta Corp.
IDTA · OTC
$0.31 +3.33% (+$0.01)
1M +3.33%
Market Cap $1.21M
P/E Ratio 8.60x
Div. Yield -
ROE 14.16%
Bulios Fair Price
$0.21
32.3% downside
Current Price
$0.31
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IDTA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 8.60x
EV/EBITDA 4.73x
P/S 0.65x
Growth
17 /100
Declining EPS growth 19.46%
Rev. growth 0.06%
FCF growth 13.19%
Profitability
77 /100
Strong Gross margin 51.53%
Net margin 7.58%
Op. margin 17.63%
Quality
71 /100
Excellent ROIC 15.99%
ROE 14.16%
ROA 5.93%
Debt
75 /100
Low Debt/Equity 0.51x
Current ratio 4.32x
Int. coverage -5.75x
Stability
48 /100
Moderate Beta 0.62x
Rev. volatility 31.38%
EPS volatility 1,007.43%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IDTA
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Amichai Glattstein
Employees
14
Headquarters
Jerusalem